🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$TSHA

Taysha Gene Therapies Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 12, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP12.16%
MAX GAP RECORD105.68%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY15.3%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL